Profound Medical Corp. (PROF)
USD 5.0
(-6.98%)
USD 5.0
(-6.98%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -28.56 Million USD | -1.48% |
| 2022 | -28.66 Million USD | 6.61% |
| 2021 | -30.69 Million USD | -41.98% |
| 2020 | -21.62 Million USD | -39.88% |
| 2019 | -15.45 Million CAD | -1.4% |
| 2018 | -15.24 Million CAD | -1.84% |
| 2017 | -14.96 Million CAD | -23.22% |
| 2016 | -12.14 Million CAD | -2.93% |
| 2015 | -11.8 Million CAD | -43.83% |
| 2014 | -8.2 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -6.91 Million USD | -11.61% |
| 2024 Q1 | -6.17 Million USD | 30.42% |
| 2023 Q1 | -6.74 Million USD | 29.24% |
| 2023 FY | -29.09 Million USD | -1.48% |
| 2023 Q4 | -9.15 Million USD | -64.54% |
| 2023 Q3 | -5.56 Million USD | 24.35% |
| 2023 Q2 | -7.35 Million USD | -9.11% |
| 2022 Q1 | -8.21 Million USD | 19.15% |
| 2022 Q3 | -4.99 Million USD | 15.73% |
| 2022 Q4 | -9.52 Million USD | -90.65% |
| 2022 Q2 | -5.93 Million USD | 27.81% |
| 2022 FY | -28.66 Million USD | 6.61% |
| 2021 FY | -30.69 Million USD | -41.98% |
| 2021 Q1 | -7.49 Million USD | -1.9% |
| 2021 Q3 | -5.99 Million USD | 14.87% |
| 2021 Q4 | -10.16 Million USD | -69.46% |
| 2021 Q2 | -7.04 Million USD | 6.08% |
| 2020 Q1 | -2.54 Million CAD | 37.9% |
| 2020 Q3 | -6.07 Million CAD | -12.99% |
| 2020 Q4 | -7.35 Million USD | -21.07% |
| 2020 FY | -21.62 Million USD | -39.88% |
| 2020 Q2 | -5.37 Million CAD | -111.48% |
| 2019 Q1 | -2.19 Million CAD | 25.3% |
| 2019 Q4 | -4.09 Million CAD | 13.52% |
| 2019 Q3 | -4.73 Million CAD | -6.39% |
| 2019 Q2 | -4.45 Million CAD | -103.09% |
| 2019 FY | -15.45 Million CAD | -1.4% |
| 2018 Q3 | -3.97 Million CAD | 10.36% |
| 2018 Q1 | -3.82 Million CAD | -10.96% |
| 2018 FY | -15.24 Million CAD | -1.84% |
| 2018 Q4 | -2.93 Million CAD | 26.16% |
| 2018 Q2 | -4.43 Million CAD | -15.94% |
| 2017 Q3 | -4.44 Million CAD | -24.23% |
| 2017 FY | -14.96 Million CAD | -23.22% |
| 2017 Q4 | -3.44 Million CAD | 22.56% |
| 2017 Q2 | -3.58 Million CAD | -16.09% |
| 2017 Q1 | -3.08 Million CAD | 8.47% |
| 2016 Q1 | -2.95 Million CAD | -77.39% |
| 2016 Q3 | -3.08 Million CAD | -9.77% |
| 2016 Q4 | -3.37 Million CAD | -9.13% |
| 2016 FY | -12.14 Million CAD | -2.93% |
| 2016 Q2 | -2.81 Million CAD | 4.78% |
| 2015 Q2 | -7 Million CAD | -16951.84% |
| 2015 Q1 | -41.09 Thousand CAD | 72.61% |
| 2015 Q4 | -1.66 Million CAD | 24.37% |
| 2015 FY | -11.8 Million CAD | -43.83% |
| 2015 Q3 | -2.2 Million CAD | 68.57% |
| 2014 Q1 | -336.32 Thousand CAD | 0.0% |
| 2014 Q4 | -150.05 Thousand CAD | 50.49% |
| 2014 FY | -8.2 Million CAD | 0.0% |
| 2014 Q3 | -303.09 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 53.635% |
| BrainsWay Ltd. | -4.19 Million USD | -580.701% |
| Cerus Corporation | -37.48 Million USD | 23.794% |
| Envoy Medical, Inc. | -29.9 Million USD | 4.477% |
| electroCore, Inc. | -18.83 Million USD | -51.688% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -222.814% |
| IceCure Medical Ltd | -14.65 Million USD | -94.984% |
| Inogen, Inc. | -102.44 Million USD | 72.114% |
| OrthoPediatrics Corp. | -20.97 Million USD | -36.211% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 45.754% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -107.847% |
| MaxCyte, Inc. | -37.92 Million USD | 24.666% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -140.896% |
| Nexalin Technology, Inc. | -4.64 Million USD | -514.558% |
| Orthofix Medical Inc. | -151.39 Million USD | 81.129% |
| PAVmed Inc | -64.17 Million USD | 55.483% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 45.549% |
| RxSight, Inc. | -48.6 Million USD | 41.226% |
| Sight Sciences, Inc. | -55.54 Million USD | 48.568% |
| SI-BONE, Inc. | -43.33 Million USD | 34.076% |
| TELA Bio, Inc. | -46.66 Million USD | 38.777% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 42.316% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -110.329% |
| Acutus Medical, Inc. | -81.66 Million USD | 65.016% |
| Talis Biomedical Corporation | -62 Million USD | 53.926% |
| Spectral AI, Inc. | -20.85 Million USD | -36.995% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 52.993% |
| CVRx, Inc. | -41.19 Million USD | 30.656% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 4562.54% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -160.778% |
| Bioventus Inc. | -156.23 Million USD | 81.713% |
| Venus Concept Inc. | -37.25 Million USD | 23.305% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 51.609% |
| LivaNova PLC | 17.54 Million USD | 262.823% |
| 908 Devices Inc. | -36.39 Million USD | 21.512% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 84.693% |
| Nemaura Medical Inc. | -14.14 Million USD | -101.99% |
| NeuroPace, Inc. | -32.95 Million USD | 13.312% |
| LENSAR, Inc. | -14.38 Million USD | -98.63% |
| Apyx Medical Corporation | -18.71 Million USD | -52.669% |
| Cutera, Inc. | -162.83 Million USD | 82.455% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -163.795% |
| BioSig Technologies, Inc. | -29.04 Million USD | 1.625% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 65.441% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -29.336% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 142.174% |
| Axonics, Inc. | -6.08 Million USD | -369.267% |
| Outset Medical, Inc. | -172.79 Million USD | 83.467% |
| IRIDEX Corporation | -9.57 Million USD | -198.527% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 73.022% |
| IRadimed Corporation | 17.19 Million USD | 266.169% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -246.543% |
| INVO Bioscience, Inc. | -8.03 Million USD | -255.574% |
| Telesis Bio, Inc. | -47.72 Million USD | 40.137% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 378.912% |
| Varex Imaging Corporation | -47.7 Million USD | 40.107% |
| Quipt Home Medical Corp. | -2.78 Million USD | -926.185% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -153.137% |
| Pulmonx Corporation | -60.84 Million USD | 53.045% |
| Dynatronics Corporation | -2.69 Million USD | -959.006% |
| Modular Medical, Inc. | -17.47 Million USD | -63.532% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -150.891% |
| Semler Scientific, Inc. | 20.58 Million USD | 238.799% |
| InMode Ltd. | 197.91 Million USD | 114.435% |
| Bruker Corporation | 427.2 Million USD | 106.688% |
| Cytosorbents Corporation | -28.5 Million USD | -0.216% |
| DexCom, Inc. | 541.5 Million USD | 105.276% |
| Align Technology, Inc. | 445.05 Million USD | 106.419% |
| Viveve Medical, Inc. | -22.02 Million USD | -29.7% |
| ZimVie Inc. | -393.28 Million USD | 92.736% |
| Movano Inc. | -29.28 Million USD | 2.438% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -135.175% |
| Nexalin Technology, Inc. | -4.64 Million USD | -514.558% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 4562.54% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 87.166% |
| Insulet Corporation | 206.3 Million USD | 113.848% |
| enVVeno Medical Corporation | -23.51 Million USD | -21.487% |
| Surmodics, Inc. | -11.54 Million USD | -147.522% |
| iCAD, Inc. | -4.84 Million USD | -489.416% |
| Nuwellis, Inc. | -20.2 Million USD | -41.368% |
| Biotricity, Inc. | -14.09 Million USD | -102.699% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 76.85% |
| Aethlon Medical, Inc. | -12.2 Million USD | -134.015% |
| InspireMD, Inc. | -19.91 Million USD | -43.447% |
| PAVmed Inc. | -64.17 Million USD | 55.483% |
| BIOLASE, Inc. | -20.63 Million USD | -38.469% |
| Beyond Air, Inc. | -60.24 Million USD | 52.576% |
| FONAR Corporation | 10.56 Million USD | 370.35% |
| AxoGen, Inc. | -21.71 Million USD | -31.557% |
| Vivani Medical, Inc. | -25.65 Million USD | -11.371% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 200.189% |
| Inari Medical, Inc. | -1.63 Million USD | -1646.271% |
| UFP Technologies, Inc. | 44.92 Million USD | 163.594% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -456.648% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -332.522% |
| Tenon Medical, Inc. | -15.58 Million USD | -83.358% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -85.2% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 19.143% |
| AdaptHealth Corp. | -678.89 Million USD | 95.792% |
| Sintx Technologies, Inc. | -8.25 Million USD | -245.914% |
| NanoVibronix, Inc. | -3.71 Million USD | -669.846% |
| Quanterix Corporation | -32.33 Million USD | 11.644% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -153.137% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 5990.515% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 90.686% |
| TransMedics Group, Inc. | -25.02 Million USD | -14.148% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -29.079% |
| NeuroMetrix, Inc. | -6.52 Million USD | -337.538% |
| Hyperfine, Inc. | -44.23 Million USD | 35.42% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 63.607% |
| Biomerica, Inc. | -5.97 Million USD | -377.902% |
| Bone Biologics Corporation | -8.94 Million USD | -219.252% |
| AVITA Medical, Inc. | -39.16 Million USD | 27.061% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -187.013% |
| Silk Road Medical, Inc | -55.74 Million USD | 48.749% |